Follow-up for medical care among drug users with hepatitis C

Evaluation and the Health Professions

Volumn 29, Issue 4, 2006, Pages 355-366

  Reynolds, Grace L ^a   Fisher, Dennis G ^a   Jaffe, Adi ^b   Edwards, Jordan ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepatitis C; Injection drug users and medical care; Referrals

Indexed keywords

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD EXAMINATION; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HEPATITIS C; HOMELESSNESS; HUMAN; INCOME; INTERVIEW; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PATIENT EDUCATION; RESIDENTIAL CARE; ULTRASOUND; VIRUS INFECTION;

ADULT; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HOMELESS PERSONS; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; PATIENT DROPOUTS; REFERRAL AND CONSULTATION; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33750728027     PISSN: 01632787     EISSN: 15523918     Source Type: Journal    
DOI: 10.1177/0163278706296003     Document Type: Article

References (27)

1. Alter, M. J. (1997). Epidemiology of hepatitis C. Hepatology, 26, 62S-65S.
2. Butt, A. A., Wagener, M., Shakil, A. O., & Ahmad, J. (2005). Reasons for non-treatment of hepatitis C in veterans in care. Journal of Viral Hepatitis, 12, 81-85.
3. Cagle, H. H., Fisher, D. G., Senter, T. P., Thurmond, R. D., & Kastar, A. J. (2002). Classifying skin lesions of injection drug users: A method for corroborating disease risk (Inventory Number AVD154). Rockville, MD: Substance Abuse and Mental Health Services Administration, National Clearinghouse for Alcohol and Drug Information. Retrieved from www.samhsa.gov/centers/clearinghouse/clearinghouses.html
4. Des Jarlais, D. C., Fisher, D. G., Newman, J. C., Trubatch, B. N., Yancovitz, M., Paone, D., et al. (2001). Providing hepatitis B vaccination to injection drug users: Referral to health clinics vs. on-site vaccination at a syringe exchange program. American Journal of Public Health, 91(11), 1791-1792.
5. Dowling-Guyer, S., Johnson, M. E., Fisher, D. G., Needle, R., Watters, J., Anderson, M., et al. (1994). Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment, 1(4), 383-392.
6. Edlin, B. R., Kresina, T. F., Raymond, D. B., Carden, M. R., Gourevitch, M. N., Rich, J. D., et al. (2005). Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clinical Infectious Disease, 40(Suppl. 5), S276-S285.
7. Fireman, M., Indest, D. W., Blackwell, A. D., Whitehead, A. J., & Hauser, P. (2005). Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): The importance of routine mental health screening as a component of a co-management model of care. Clinical Infectious Disease, 40(Suppl. 5), S286-S291.
8. Fishbein, D. A., Lo, Y., Reinus, J. F., Gourevitch, M. N., & Klein, R. S. (2004). Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. Journal of Acquired Immune Deficiency Syndromes, 37(3), 1367-1375.
9. Fisher, D. G., Fenaughty, A. M., Paschane, A. A., Paschane, D. M., Cagle, H. H., & Orr, S. M. (1997). Hepatitis C virus among Alaskan drug users. American Journal of Public Health, 87(10), 1722-1724.
10. Fisher, D. G., Reynolds, G. L., Jaffe, A., & Perez, M. J. (2006). Hepatitis and human immunodeficiency virus co-infection among injection drug users in Los Angeles County, California. Journal of Addictive Diseases, 25(2), 25-32.
11. Fry, C. L., & Lintzeris, N. (2003). Psychometric properties of the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ). Addiction, 98, 171-178.
12. Fultz, S. L., Justice, A. C., Butt, A. A., Rabeneck, L., Weissman, S., Rodriguez-Barradas, M., et al. (2003). Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection. Clinical Infectious Disease, 36, 1039-1046.
13. Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., & Vlahov, D. (1998). Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes, 18(Suppl. 1), S11-S19.
14. Giordano, T. P., Visnegarwala, F., White, A. C. J., Troisi, C. L., Frankowski, R. F., Hartman, C. M., et al. (2005). Patients referred to an urban HIV clinic frequently fail to establish care: Factors predicting failure. AIDS Care, 17(6), 773-783.
15. Hagan, H., Thiede, H., & Des Jarlais, D. C. (2005). HIV/hepatitis C virus co-infection in drug users: Risk behavior and prevention. AIDS, 19(Suppl. 3), S199-S207.
16. Huckans, M. S., Blackwell, A. D., Harms, T. A., Indest, D. W., & Hauser, P. (2005). Integrated hepatitis C virus treatment: Addressing co-morbid substance use disorders and HIV infection. AIDS, 19(Suppl 3), S106-S115.
17. Johnson, M. E., Fisher, D. G., Fenaughty, A. M., & Theno, S. A. (1998). Hepatitis C virus and depression in drug users. American Journal of Gastroenterology, 93(5), 785-789.
18. Kim, W. R. (2002). The burden of hepatitis C in the United States. Hepatology, 36(5, Suppl. 1), S30-S34.
19. Kresina, T. F., Bruce, R. D., Cargill, V. A., & Cheever, L. W. (2005). Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users co-infected with HIV and HCV. Clinical Infectious Disease, 41(Suppl. 1), S83-S88.
20. Mehta, S. H., Thomas, D. L., Sulkowski, M. S., Safaein, M., Vlahov, D., & Strathdee, S. A. (2005). A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users. AIDS, 19(Suppl. 3), S179-S189.
21. Needle, R., Weatherby, N., Chitwood, D., Booth, R., Watters, J., Fisher, D. G., et al. (1995). Reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors, 9(4), 242-250.
22. Pollio, D. E., Sptznagel, E. L., North, C. S., Thompson, S., & Foster, D. A. (2000). Service use over time and achievement of stable housing in a mentally ill homeless population. Psychiatric Services, 51(12), 1536-1543.
23. Stein, M. D., Maksad, J., & Clarke, J. (2001). Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment. Drug and Alcohol Dependence, 61, 211-215.
24. Stoove, M. A., Gifford, S. M., & Dore, G. J. (2005). The impact of injecting drug use status on hepatitis C-related referral and treatment. Drug and Alcohol Dependence, 77(1), 81-86.
25. Strauss, S. M., Falkin, G. P., Vassilev, Z. P., Des Jarlais, D. C., & Astone, J. (2002). A nationwide survey of hepatitis C services provided by drug treatment programs. Journal of Substance Abuse Treatment, 22, 55-62.
26. Strauss, S. M., Vassilev, Z. P., & Des Jarlais, D. C. (2003). Provision of hepatitis E education in a nationwide sample of drug treatment programs. Journal of Drug Education, 33(1), 107-117.
27. Trubatch, B. A., Fisher, D. G., Cagle, H. H., & Fenaughty, A. M. (2000). Vaccination strategies for targeted and difficult-to-access groups. American Journal of Public Health, 90(3).